J9278 Carboplatin (avyxa) - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Carboplatin (avyxa)

Brand Name:

Kyxata

Strength:

1mg

HCPCS:

J9278

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Alkylating Agent

Minor Drug Class:

Platinum Compound

Oral (Y/N):

No

FDA Approval Year:

2025

FDA Discontinuation Year:

CMS Effective Date:

March 18, 2026

CMS Discontinuation Date:

Status:

In Use